Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...

Another biomarker may spot future risk sooner, but experts say more evidence is needed before it reshapes screening.

The longtime ABC New York anchor and his wife, Kathleen Friery, open up about the subtle memory changes, months of testing ...

Scientists may have uncovered a crucial clue to one of the biggest mysteries in Alzheimer's disease: why some people develop ...

"SuperAgers" keep razor-sharp memories past 80, but a new study shows this is not just down to good genes.

Laredo dementia specialist Jose Angel Hernandez wrote a children's book to help families discuss Alzheimer's disease with ...

The NHS has entered negotiations to roll out the first drugs shown to slow Alzheimer’s disease. Health officials and manufacturers have begun talks aimed at reaching a price that could allow the ...

The House plans on Wednesday to take up bills addressing Alzheimer's and dementia and home care services for people with ALS, ...

Researchers have identified a set of 34 circular RNAs in blood that can detect Alzheimer’s disease with striking accuracy and ...

A blood-based biomarker measuring amyloid beta protein misfolding has demonstrated superior predictive accuracy for ...

When it comes to Alzheimer’s disease, two individuals can have similar risk factors, but their outcomes can differ significantly. There is a molecule at the interface between blood ...

In ALZ Fired Up!, newly published by Palmetto Publishing, a man diagnosed with Alzheimer’s disease at sixty chronicles his two-year fight to reclaim agency from a disease with no cure. ALZ Fired Up!